US Patent 11988668 Concentration-dependent self-interaction assay
Patent 11988668 was granted and assigned to Regeneron Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+22 properties)
Article (+418 characters)
US Patent 11988668 Concentration-dependent self-interaction assay
Article
Patent abstract
Methods for producing high concentration protein formulations having high stability are provided. Assays for selecting proteins and formulation conditions that have high self-repulsive attributes are used as an early step in the manufacturing process. Specifically, a protein concentration-dependent self-interaction nanoparticle spectroscopy method is employed as a protein colloidal interaction assay.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Michael Marlow0
Michael Schneider0
Michael Sennett0
Date of Patent
May 21, 2024
0Patent Application Number
178689830
Date Filed
July 20, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11988668 Concentration-dependent self-interaction assay
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
